期刊文献+

N-Boc-(S)-二羟甲基吗啉的合成研究 被引量:1

Study on synthesis of N-boc-(S)-2-(hydroxymethyl)morpholine
下载PDF
导出
摘要 研究讨论了以D-甘露醇为原料,经过丙叉化反应,高碘酸钠氧化,通过引入苄胺使手性碳原子构型发生转变。接着进行氯乙酰化、醋酸脱丙叉以及碱性环境下关环反应。还原内酰胺生成(S)-N-苄基-2-羟甲基吗啉,Pd/C催化脱苄基,最后上叔丁氧羰基保护,制得标题化合物,总产率约35%。 This paper describes the synthesis in six steps of the derivations of N-Boc-(S)-2-(hydroxymethyl)morpholine in an overall yield of 35%.The optically active compounds of 4-Boc-2-hydroxymethylmorpholine were prepared from D-mannitol by practical procedures.As a frequently used chiral pool,D-mannitol has been finding extensive application in the organic synthesis.Our approach was to build the chiral morpholine moiety.Firstly,the cleavage of di-O-isopropylidene-1,2∶5,6-D-mannitol with sodium metaperiodate was realized,followed by reductive amination of O-isopropylidene-(R)-glyceraldehyde with benzylamine in the presence of sodium borohydride.Acylation with chloroacetyl chloride,and removal of the isopropylidene group in aqueous acetic acid gave the diol,which was treated with sodium ethoxide to yield the lactam.N-tert-Butoxycarbonylmorpholine was prepared through the hydride reduction of lactam,the reductive removal of the benzyl group with palladium on carbon in H2,and the subsequent tert-butoxycarbonylation with Boc-2-O-(di-tert-butyl dicarbonate).
机构地区 同济大学化学系
出处 《化学试剂》 CAS CSCD 北大核心 2009年第8期595-597,654,共4页 Chemical Reagents
基金 同济大学理科基金资助项目(1380219063)
关键词 N-叔丁氧羰基-(S)-2-羟甲基吗啉 D-甘露醇 合成反应 药物中间体 N-Boc-(S)-2-(hydroxymethyl)morpholine D-mannitol pharmaceutical intermediates synthesis
  • 相关文献

参考文献11

  • 1GREENWOOD D T, MALLION K B, TODD A H, et al. 2- Aryloxymethyl-2,3,5,6-tetrahydro-1,4-oxazines,a new class of antidepressants [ J]. J. Med. Chem. , 1975,18 : 573.
  • 2GUO H Y,LORENZ R R,VERBEUREN T J,et al. Effects of S-11701 on allumulation, release and metabolism of norepinephrine in isolated canine saphenous veins[J]. Gernal Pharmacology, 1992,23(6) : 1 079-1 085.
  • 3BRENNER E, BALDWIN R M, TAMAGNAN G. Asymmeteic synthesis of ( + )-( S, S)-reboxetine ria a new (S)-2-(hydroxymethyl) morpholine preparation [ J]. Org. Lett., 2005, 7:937-939.
  • 4Sankyo Co. , Ltd., Japan. Patent, JP03-130 282. Cumarine derivatine[ J] . Chem. Abstr. , 1991,115:71 396.
  • 5WAGLE D R, MONTELEONE M G. Novel synthesis of optically active morpholines[J]. Chem. Soc. , Chem. Commun. , 1989:915-916.
  • 6BENNIS K, CALINAUD P, JACQUES G. A new route to some enantiomerically pure substituted morpholines from D-ribono and D-gulono-1,4-lactones [ J ] . J. Carbohydr. Res. , 1994, 264:33-44.
  • 7LAINTON J A H,ALLEN M C,BURTON M.Design and synthesis of a diverse morpholine template library [ J ]. Comb. Chem. , 2003,5:400-407.
  • 8WILKINSON M C. Asymmetric synthesis of an aminomethyl morpholine via double allylic substitution [ J ]. Tetrahedron Lett. ,2005, (46):4 773-4 775.
  • 9PORZI G. Synthesis of uncommon tripeptides derived from 2,6-diaminopimelic acid [ J ] . Tetrahedron : Asymmetry, 2001, 12:3 319-3 324.
  • 10唐智荣,黄虹,饶炬,程树军.吗啉二酮衍生物与丙交酯的共聚[J].华东理工大学学报(自然科学版),2002,28(6):618-620. 被引量:9

二级参考文献5

  • 1Jacob J, Jian T, Yang Z H, et al. Synthesis and characterization of anhydride-functional polycaprolactone [J]. J Polym Sci, Part A: Polym Chem, 1997, 35(6):1 139-1 148.
  • 2Barrera D A, Zylstra E, Lansbury P T, et al. Copolymerization and degradation of poly (lactic acid-co-lysine) [J]. Macromolecules, 1995, 28:425-432.
  • 3Wang D, Feng X D. Synthesis of poly (glycollic acid-alter-L-aspartic acid) from a morpholine-2,5-dione delivative [J]. Macromolecules, 1997, 30:5 688-5 692.
  • 4Hans R K, Ingrid K. Polyactones B. Transesterification of poly (L-lactone) with poly (glycolide), ploy (β-propiolactone), and poly (ε-caprolactone) [J]. J Maccromol Sci Chem, 1987, A24(11):1 345-1 356.
  • 5Wang D, Feng X D. Copolymerization of ε-caprolactone (3S)-3-[(benzyloxycarbonyl) methyl]morpholine-2,5-dione and 13C-NMR sequence analysis of the copolymer [J]. Macromolecules, 1998, 31:3 824-3 831.

共引文献8

同被引文献7

  • 1Diane H Boschelli,Wang Daniel,Wang Yan,et al.Optimi-zation of 7-alkene-3-quinolinecarbonitriles as srckinase in-hibitors[J].Bioorganic&Medicinal Chemistry Letters,2010(20):2924-2927.
  • 2Christopher W Murray,Maria G Carr,Owen Callaghan,et al.Fragment-based drug discovery applied to Hsp 90.discovery of two lead series with high ligand efficiency[J].J Med Chem,2010(53):5942-5955.
  • 3Edwin Andres Correa,Edward D Hogestatt,Olov Sterner,et al.In vitro TRPV1 activity of piperine derived amides[J].Bioorganic&Medicinal Chemistry,2010(18):3299-3306.
  • 4Scott E Denmark,Tetsuya Kobayashi,Christopher S Re-gens.Total synthesis of(+)-papulacandin D[J].Tetra-hedron,2010(66):4745-4759.
  • 5Erik L Meremereredith,Kimberly Beattie,Bobin Burgis,etal.Identification of potent and selective amidobipyridyl in-hibitors of protein kinase D[J].J Med Chem,2010(53):5422-5438.
  • 6Sampath-Kumaranandan,Richard D Gless.Exploration ofsecondary and tertiary pharmacophores in unsymmetricalN,N’-diaryl urea inhibitors of soluble epoxide hydrolase[J].Bioorganic&Medicinal Chemistry Letters,2010(20):2740-2744.
  • 7陈冬梅,张雁芳,杨日芳,汪海.吗啉环和哌嗪环类新衍生物对血管舒张功能的影响[J].中国药理学通报,2003,19(7):754-758. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部